Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00097552
Status:
COMPLETED
Last Update Posted:
2012-11-14
First Post:
2004-11-24
Brief Title:
A Study to Evaluate Subjects With Turner Syndrome Treated With Growth Hormone
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Study Overview
Official Title:
Characterization of Subjects With Turner Syndrome Treated With Growth Hormone in the National Cooperative Growth Study NCGS
Status:
COMPLETED
Status Verified Date:
2012-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a multicenter open-label observational postmarketing surveillance study of Genentech growth hormone GH products in the treatment of girls with Turner syndrome in the United States and Canada
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None